Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
07/10/2007 | CA2108466C Hcv genomic sequences for diagnostics and therapeutics |
07/10/2007 | CA2087818C Oligonucleotide analogs, their preparation and use |
07/10/2007 | CA2060455C Reverse antimicrobial peptides, antimicrobial oligopeptides and other antimicrobial compositions, and methods of their production and use, particularly to provide protection against plant pathogens |
07/05/2007 | WO2007075872A2 Nitroimidazole compounds |
07/05/2007 | WO2007075794A2 Oral formulations comprising tigecycline |
07/05/2007 | WO2007075792A1 Methods of treating gastrointestinal tract infections with tigecycline |
07/05/2007 | WO2007075605A2 Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type and type 2 cytokine production |
07/05/2007 | WO2007075281A1 Denaturant for ethanol |
07/05/2007 | WO2007075102A1 Medicinal agent for treating viral infections |
07/05/2007 | WO2007075094A1 New derivatives of epirubicin, their medicinal application and pharmaceuticaly acceptable forms of drugs |
07/05/2007 | WO2007075092A1 New derivatives of epirubicin, their medicinal application and pharmaceuticals acceptable forms of drugs |
07/05/2007 | WO2007074871A1 Novel cxcr4 antagonist and use thereof |
07/05/2007 | WO2007074868A1 Novel arylamidine derivative, salt thereof and antifungal agent containing those |
07/05/2007 | WO2007074859A1 Anti-c-mannosylated peptide antibody and use thereof |
07/05/2007 | WO2007074727A1 Remedy for oral moniliasis |
07/05/2007 | WO2007074604A1 Nanoparticle containing water-soluble non-peptidic low molecular weight substance |
07/05/2007 | WO2007074471A1 Anti hiv-1 active bacterial and baculovirus recombinant epap-1 |
07/05/2007 | WO2007074340A1 Process for the preparation of porphyrin derivatives as antimicrobial agents by photodynamic therapy (pdt) |
07/05/2007 | WO2007074200A1 Inhibitor of the uracil-dna glycosylase enzyme and uses thereof |
07/05/2007 | WO2007074185A1 Antimicrobial cyclic peptides |
07/05/2007 | WO2007074171A1 Aza heterocyclics for the treatment of malaria or aids |
07/05/2007 | WO2007074170A2 Compositions and methods for the treatment and prevention of disease |
07/05/2007 | WO2007073855A1 Use of adenosine a1 receptor agonists for the protection of renal cells against toxic effects caused by aminoglycosides during treatment of infectious diseases |
07/05/2007 | WO2007073785A1 Therapeutic use of an extract from the leaves of nerium oleander |
07/05/2007 | WO2007073703A1 Cytoprotective pharmaceutical combination which can be used in the prevention and treatment of systemic inflammatory response syndrome |
07/05/2007 | WO2007073583A1 A method of treatment and agents useful for same |
07/05/2007 | WO2007058392A9 Heterocyclic compound and medicinal application thereof |
07/05/2007 | WO2007057436A3 Interferon in influenza |
07/05/2007 | WO2007048820A3 Micronised azodicarbonamide, the preparation and use thereof |
07/05/2007 | WO2007043094A3 6-vinyl pyrimidine and pyrimidinone derivatives and the use thereof |
07/05/2007 | WO2007027560A3 Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents |
07/05/2007 | WO2007014940A8 Quinoline derivatives as antibacterical agents |
07/05/2007 | WO2006021210A3 Binding member towards pneumolysin |
07/05/2007 | US20070157326 Ee3-protein family and corresponding dna sequence |
07/05/2007 | US20070155966 Heterocyclic imines such as 2,2-Dichloro-N-[2-[3-(2-chloro-6-fluorophenyl)-5-isoxazolyl]-(4-pyridyl)]Acetamide, used for prophylaxis of hepatitis C virus (HCV) |
07/05/2007 | US20070155959 Protease inhibitor conjugates and antibodies useful in immunoassay |
07/05/2007 | US20070155841 Preventive agent for carcinogenesis of liver cancer containing quinone-based compound as active ingredient |
07/05/2007 | US20070155814 Immunomodulatory compositions |
07/05/2007 | US20070155812 Thio-substituted phenbutazone compounds as anti-inflammatory, anti-viral and immunomodulatory agents |
07/05/2007 | US20070155810 Enzyme inhibitors as bactericides for infections and enzyme inhibitors |
07/05/2007 | US20070155756 Treatment of chemokine mediated diseases |
07/05/2007 | US20070155740 1-(1H-Pyrazin-2-on-3-yl)-tetrahydroquinolines or tetrahydro-1,4-benzoxazines (3-(8-Bromo-6-methoxy-1,2,3,4-tetrahydroquinoline)-5-chloro-1-(1-ethylpropyl)-2(1H)-pyrazinone); affective disorder, anxiety and depression |
07/05/2007 | US20070155734 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
07/05/2007 | US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents |
07/05/2007 | US20070155724 Methods of Treating Cytokine Mediated Diseases |
07/05/2007 | US20070155714 Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections |
07/05/2007 | US20070155713 Nitrogen-containing heterocyclic compounds and use thereof |
07/05/2007 | US20070155698 Oxazaborolidines as bacteria effectors |
07/05/2007 | US20070155683 Containing a single-stranded oligonucleotide DNA molecule containing one or more CpG(s); SARS virus, hepatitis C virus, dengue virus and Japanese encephalitis, influenza virus |
07/05/2007 | US20070155670 Pyrrolidine Melanocortin-Specific Compounds |
07/05/2007 | US20070154995 Development of human monoclonal antibodies and uses thereof |
07/05/2007 | US20070154986 Streptococcus pneumoniae Polynucleotides and Sequences |
07/05/2007 | US20070154943 Methods for preventing cattle reproductive diseases |
07/05/2007 | US20070154905 Modulators of the function of fas receptors and other proteins |
07/05/2007 | US20070154902 Papilloma virus vaccine |
07/05/2007 | US20070154486 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin |
07/05/2007 | US20070154468 Use of CD28-specific monoclonal antibodies for producing a pharmaceutical composition for treating virus infections |
07/05/2007 | CA2635770A1 Inhibition of cxcr4 and/or cell motility by phenylalanine, cysteine or peptides containing said aminoacids |
07/05/2007 | CA2635359A1 Compositions and methods for synthesizing heterocyclic therapeutic compounds |
07/05/2007 | CA2635342A1 Cytoprotective pharmaceutical combination which can be used in the prevention and treatment of systemic inflammatory response syndrome |
07/05/2007 | CA2634846A1 Novel arylamidine derivative, salt thereof and antifungal agent containing those |
07/05/2007 | CA2634630A1 Process for the preparation of porphyrin derivatives as antimicrobial agents by photodynamic therapy (pdt) |
07/05/2007 | CA2634113A1 Quinolin- 4 - one derivatives as modulators of abc transporters |
07/05/2007 | CA2633424A1 Pharmaceutical compositions containing protein nma0939 |
07/05/2007 | CA2632262A1 Method of using .beta.-hydroxy-.beta.-methylbutyrate |
07/05/2007 | CA2632213A1 Oral formulations comprising tigecycline |
07/05/2007 | CA2631661A1 Nitroimidazole compounds |
07/05/2007 | CA2631632A1 Methods of treating gastrointestinal tract infections with tigecycline |
07/04/2007 | EP1804062A2 YKL-40 as a marker and prognostic indicator for cancers |
07/04/2007 | EP1803811A1 Chimeric (double) decoy |
07/04/2007 | EP1803810A1 Integrin antagonists |
07/04/2007 | EP1803730A1 Albumin fusion proteins |
07/04/2007 | EP1803706A1 HIV protease inhibitors based on amino acid derivatives |
07/04/2007 | EP1803463A1 Extracts from hypericum L. species useful for the treatment of persistent tuberculosis |
07/04/2007 | EP1803453A1 Carbamate antibiotics |
07/04/2007 | EP1803450A1 Pharmaceutical compositions for the eradication of helicobacter pylori |
07/04/2007 | EP1803448A2 Tasted masked veterinary solid compositions |
07/04/2007 | EP1802650A2 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection |
07/04/2007 | EP1802643A1 Antiviral oligonucleotides |
07/04/2007 | EP1802619A1 Inhibitors of the hiv integrase enzyme |
07/04/2007 | EP1802327A1 Combination anti-viral compositions comprising castanospermine and methods of use |
07/04/2007 | EP1802319A1 Lactic acid bacteria strains useful against urogenital pathogens and compositions containing same |
07/04/2007 | EP1802318A1 Lactic acid bacteria strains useful against gastrointestinal pathogens and compositions containing same |
07/04/2007 | EP1802315A2 Combination therapy for treating viral infections |
07/04/2007 | EP1802311A1 4-aminophenyl morpholinone derivatives for the treatment of hepatitis c |
07/04/2007 | EP1802302A1 NOVEL USE OF a-SYMPATHOMIMETICS HAVING A 2-IMIDAZOLINE STRUCTURE |
07/04/2007 | EP1802297A2 Compositions and methods for treatment of disease caused by yersinia spp infection |
07/04/2007 | EP1802291A2 Calixarene-based peptide conformation mimetics, methods of use, and methods of making |
07/04/2007 | EP1494688A4 Use of topical compositions for the control of microbial diseases of the nail |
07/04/2007 | EP1484971B1 Use of 4-aminopyrimidines for the antimicrobial treatment of surfaces |
07/04/2007 | EP1412380B1 Broad spectrum antibiotic peptides of the phylloseptin family |
07/04/2007 | EP1286964B1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3 |
07/04/2007 | EP1286690B1 Use of alpha-msh and epo for the manufacture of a medicament for preventing or treating ischemic conditions |
07/04/2007 | EP1194560B1 Antigenic neisserial peptides |
07/04/2007 | EP1159427B1 Gp120 mutants and biological applications |
07/04/2007 | EP1121382B9 Interferon-beta fusion proteins and uses |
07/04/2007 | EP0994716B2 Maternal immune secretions and their use in the treatment and/or prophylaxis of conditions of the human body |
07/04/2007 | EP0567566B2 Methods for treating tumor necrosis factor mediated diseases |
07/04/2007 | CN1993332A Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors |
07/04/2007 | CN1990874A Gene clone of hepatitis B virus front S1 region multi-epitope antigen and encoding sequence thereof |